Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LGALS3 | P17931 | 8/20 | 0.43 |
| ▸ | LGALS9 | O00182 | 6/20 | 0.43 |
| ▸ | LGALS1 | P09382 | 6/20 | 0.43 |
| ▸ | LGALS7; LGALS7B | P47929 | 5/20 | 0.43 |
| ▸ | LGALS8 | O00214 | 5/20 | 0.37 |
| ▸ | SELP | P16109 | 3/20 | 0.34 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.33 |
| ▸ | SELE | P16581 | 1/20 | 0.33 |
| ▸ | HK1 | P19367 | 2/20 | 0.32 |
| ▸ | HK2 | P52789 | 2/20 | 0.32 |
| ▸ | MAOB | P27338 | 1/20 | 0.32 |
| ▸ | LGALS4 | P56470 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18385919 | 0.88 | ALDH1A1 (0.37) | LGALS3LGALS9LGALS1LGALS7; LGALS7BALDH1A1 | |
| SCHEMBL18393015 | 0.83 | LGALS3 (0.40) | LGALS3LGALS9LGALS1LGALS7; LGALS7BLGALS8 | |
| SCHEMBL18385940 | 0.83 | LGALS3 (0.40) | LGALS3LGALS9LGALS1LGALS7; LGALS7BLGALS8 | |
| SCHEMBL19090195 | 0.78 | LGALS3 (0.58) | LGALS3LGALS9LGALS1LGALS7; LGALS7BLGALS8 | |
| SCHEMBL20381817 | 0.78 | LGALS3 (0.39) | LGALS3LGALS9LGALS1LGALS7; LGALS7BLGALS8 | |
| SCHEMBL13804400 | 0.76 | LGALS3 (0.61) | LGALS3LGALS9LGALS1LGALS7; LGALS7BLGALS8 | |
| SCHEMBL13814628 | 0.76 | LGALS3 (0.61) | LGALS3LGALS9LGALS1LGALS7; LGALS7BLGALS8 | |
| SCHEMBL14878331 | 0.76 | LGALS3 (0.61) | LGALS3LGALS9LGALS1LGALS7; LGALS7BLGALS8 | |
| SCHEMBL14900285 | 0.76 | LGALS3 (0.61) | LGALS3LGALS9LGALS1LGALS7; LGALS7BLGALS8 | |
| SCHEMBL13804416 | 0.76 | LGALS3 (0.61) | LGALS3LGALS9LGALS1LGALS7; LGALS7BLGALS8 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10023603-B2 | Preparation of monosaccharides, disaccharides, trisaccharides, and pentasaccharides of heparinoids | FORMOSA LABORATORIES, INC. (TW) | 2018-07-17 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10023603-B2 | Preparation of monosaccharides, disaccharides, trisaccharides, and pentasaccharides of heparinoids | HPSE, DDOST, FUT5 | LGALS3 174/4885LGALS9 341/4885LGALS1 237/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.